Novel mutation of SCN9A gene causing generalized epilepsy with febrile seizures plus in a Chinese family.
Tian ZhangMingwu ChenAngang ZhuXiaoguang ZhangTao FangPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
Generalized epilepsy with febrile seizures plus (GEFS+) is a complex familial epilepsy syndrome. It is mainly caused by mutations in SCN1A gene, encoding type 1 voltage-gated sodium channel α-subunit (NaV1.1), and GABRA1 gene, encoding the α1 subunit of the γ-aminobutyric acid type A (GABAA) receptor, while seldom related with SCN9A gene, encoding the voltage-gated sodium channel NaV1.7. In this study, we investigated a Chinese family with an autosomal dominant form of GEFS+. DNA sequencing of the whole coding region revealed a novel heterozygous nucleotide substitution (c.5873A>G) causing a missense mutation (p.Y1958C). This mutation was predicted to be deleterious by three different bioinformatics programs (The polyphen2, SIFT, and MutationTaster). Our finding reports a novel likely pathogenic SCN9A Y1958C heterozygous mutation in a Chinese family with GEFS+ and provides additional supports that SCN9A variants may be associated with human epilepsies.
Keyphrases
- copy number
- genome wide
- early onset
- genome wide identification
- single cell
- gene expression
- temporal lobe epilepsy
- dna methylation
- emergency department
- single molecule
- urinary tract infection
- autism spectrum disorder
- atomic force microscopy
- circulating tumor
- intellectual disability
- transcription factor
- cell free
- protein kinase
- adverse drug
- high resolution
- pluripotent stem cells